Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenue:        
Total revenue $ 13,369 $ 12,835 $ 41,021 $ 35,306
Costs and expenses:        
Cost of revenue 13,601 9,188 37,786 25,058
Selling, general and administrative 26,592 3,370 55,791 9,178
Research and development 5,010 2,190 11,604 5,565
Gain (loss) on sale of assets 0 (0) 33 (9)
Total costs and expenses 45,203 14,748 105,214 39,792
Loss from operations (31,834) (1,913) (64,193) (4,486)
Nonoperating income (expense):        
Gain (loss) on remeasurement of private warrants 28,392 0 6,435 0
Interest expense, net (246) (334) (668) (1,431)
Gain on forgiveness of debt 0 0 1,776 0
Loss on debt extinguishment 0 0 (2,604) 0
Other income (expense), net 90 108 170 297
Total nonoperating income (expenses) 28,236 (226) (5,109) (1,134)
Loss before income taxes (3,598) (2,139) (59,084) (5,620)
Income taxes 11,423 0 11,423 0
Net income (loss) $ 7,825 $ (2,139) $ (47,661) $ (5,620)
Net loss per share:        
Basic net income (loss) per share $ 0.08 $ (0.07) $ (0.53) $ (0.20)
Diluted net income (loss) per share $ 0.08 $ (0.07) $ (0.53) $ (0.20)
Weighted average number of shares used to compute basic net income (loss) per share 98,160,626 29,317,058 90,614,910 28,699,250
Dilutive effect of warrants and stock options 5,360,126      
Weighted average number of shares used to compute diluted net income (loss) per share 103,520,752 29,317,058 90,614,910 28,699,250
Products        
Revenue:        
Total revenue $ 12,397 $ 11,249 $ 34,715 $ 31,004
Services        
Revenue:        
Total revenue $ 972 $ 1,586 $ 6,306 $ 4,302